Skip to main content

MPL proto-oncogene, thrombopoietin receptor

The MPL gene provides instructions for making the thrombopoietin receptor protein, which promotes the growth and division (proliferation) of cells. This receptor is especially important for the proliferation of certain blood cells called megakaryocytes, which produce platelets, the cells involved in blood clotting. Research suggests that the thrombopoietin receptor may also play a role in the maintenance of hematopoietic stem cells, which are stem cells located within the bone marrow that have the potential to develop into red blood cells, white blood cells, and platelets.

Video picks for Genes
Video library

Normal function

The MPL gene provides instructions for making the thrombopoietin receptor protein, which promotes the growth and division (proliferation) of cells. This receptor is especially important for the proliferation of certain blood cells called megakaryocytes, which produce platelets, the cells involved in blood clotting. Research suggests that the thrombopoietin receptor may also play a role in the maintenance of hematopoietic stem cells, which are stem cells located within the bone marrow that have the potential to develop into red blood cells, white blood cells, and platelets.

The thrombopoietin receptor is turned on (activated) when a protein called thrombopoietin attaches (binds) to it. The activated thrombopoietin receptor stimulates a signaling pathway called the JAK/STAT pathway, which transmits chemical signals from outside the cell to the cell's nucleus and is important for controlling the production of blood cells.

Conditions referring to this gene or chromosome

Other names

C-MPL

CD110

MPLV

myeloproliferative leukemia protein

myeloproliferative leukemia virus oncogene

proto-oncogene c-Mpl

thrombopoietin receptor

thrombopoietin receptor precursor

TPO-R

TPOR

TPOR_HUMAN

Patient picks for Genes

Related patient information and medicines

Myelofibrosis

Patient information leaflet

Myelofibrosis

Myelofibrosis is a serious bone marrow disorder that disrupts your body's normal production of blood cells. This leads to reduced levels of: Red blood cells (erythrocytes). This causes anaemia Anaemia. Already having another blood disorder, such as essential thrombocythaemia or polycythaemia rubra vera. Having a gene mutation such as JAK2, CALR,.

Immune thrombocytopenic purpura

Patient information leaflet

Immune thrombocytopenic purpura

Immune thrombocytopenic purpura (ITP) is an autoimmune disorder. In ... Thrombocytopenic , or thrombocytopenia, means not having enough platelets. The National Institute for Health and Care Excellence (NICE) has looked at the evidence for this medicine and advised that it can be used when other medicines have been tried. Specifically, these other.

Coronary artery bypass graft

Patient information leaflet

Coronary artery bypass graft

C oronary artery bypass grafting (CABG) is a type of heart surgery to treat coronary artery disease. The standard surgery requires open heart surgery and stopping of the heart temporarily. Coronary artery bypass grafting, called CABG for ... Ventricular arrhythmias Abnormal heart rhythms - abnormal heart rhythms which can sometimes be serious..

Familial hypercholesterolaemia

Patient information leaflet

Familial hypercholesterolaemia

Hypercholesterolaemia means cholesterol levels in your blood are too high. Too much cholesterol in your blood causes cholester... What genes are involved in familial hypercholesterolaemia (FH). Dr Krishna Vakharia , 13th September 2024 The National Institute for Health and Care Excellence (NICE) is recommending evinacumab alongside diet and other.

Mastocytosis and mast cell disorders

Patient information leaflet

Mastocytosis and mast cell disorders

If the condition is severe, surgery to remove the spleen (splenectomy), medicines that have an effect on the immune system (such as interferon), bone marrow transplant or... Dr Sarah Jarvis , 28th September 2021 Midostaurin for treating advanced systemic mastocytosis The National Institute for Health and Care Excellence (NICE) has brought out new.

Breast cancer

Patient information leaflet

Breast cancer

What is breast cancer? | Patient Explainers Breast cancer is the most common cancer in women. ...) Follow Patient: Website: [https://patient.info/](https://patient.info/) Facebook: [https://www.facebook.com/patient](https://www.facebook.com/patient) Twitter: [https://twitter.com/patient](https://twitter.com/patient) Pinterest:.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 14 Apr 2023 | Latest version
  • 1 Sept 2014 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.